Trial Profile
A Phase IV, Multi-centre, Randomised, Double-Blind Study to Evaluate the Efficacy and Safety of NK- 104 versus Atorvastatin in Chinese Patients with Hypercholesterolaemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2018
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Kowa
- 01 Jun 2016 New trial record